Condition
Chronic Diabetic Foot Ulcer
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.6% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05849701Not ApplicableCompletedPrimary
Shock Wave Versus Vacuum Assisted Closure on Chronic Diabetic Foot Ulcer
NCT05338463Phase 4CompletedPrimary
Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients
NCT04838600Terminated
A PMCF Investigation on Chronic LU and DFU in Need of Debridement With ChloraSolv®
NCT00709514Phase 2CompletedPrimary
Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers
Showing all 4 trials